Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881279 · ClinicalTrials.gov registry record
Maintaining Optimal Trauma Outcomes: Resilience in the Midst of a Ransomware Attack
A clinical trial of Trauma and Electronic Health Record, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 846
- Enrollment target
- 1
- Study location
NCT04881279: Completed study of Trauma and Electronic Health Record, sponsored by State University of New York at Buffalo.
NCT04881279 is a study of Trauma and Electronic Health Record that has completed, run by State University of New York at Buffalo. The registered enrollment target is 846 participants, above the 292-participant average among 56 other Trauma trials with a reported enrollment target (190% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881279, a study of Trauma and Electronic Health Record, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 846 participants
- Enrollment target
- 1
- Study location
Study Summary
Retrospective review of de-identified hospital emergency room and trauma registry data and operating room case logs from April 9th through June 9th, 2016, 2017 examining outcomes as affected by a ransomware attack in a level I trauma center
Primary Outcome
Hospital and ICU length of stay (LOS) in days And in-hospital mortality between cohorts expressed as percentage of cohort
Conditions Studied
Interventions
- OTHER Event
Study Locations (1)
New York
- Erie County Medical Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 846 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2017-06-30 |
What the finished NCT04881279 record still lists
NCT04881279 is an observational study that tracks outcomes without assigning an intervention. The registered 846 participants enrollment target is mid-sized for trials with a published cap, above the 292-participant average among 56 other Trauma trials with a reported enrollment target (190% higher).
The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Event is the first listed.
NCT04881279 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04881279 about?
NCT04881279 is a clinical study titled "Maintaining Optimal Trauma Outcomes: Resilience in the Midst of a Ransomware Attack". Retrospective review of de-identified hospital emergency room and trauma registry data and operating room case logs from April 9th through June 9th, 2016, 2017 examining outcomes as affected by a ransomware attack in a level I trauma center
What is the current status of trial NCT04881279?
This trial is currently completed. The enrollment target is 846 participants. The study started on 2017-04-01. Estimated completion is 2017-06-30.
What conditions does trial NCT04881279 study?
This clinical trial studies the following conditions: Trauma, Electronic Health Record.
What interventions are being tested in trial NCT04881279?
The interventions under investigation include: Event (OTHER).
Who is sponsoring clinical trial NCT04881279?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04881279 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04881279's enrollment target sits among peer trials
846 5th of 56 higher than 52 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02757859 · 845 participants · NA
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
- NCT07142408 · 848 participants · Phase 3
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
- NCT06747949 · 844 participants · Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- NCT06439979 · 843 participants · NA
Rural Adult and Youth Sun Protection Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI